Chong Zhang

9PUBLICATIONS
19CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 24, 2025
Phosphodiesterase 1A physically interacts with YTHDF2 and reinforces the progression of non-small cell lung cancer.

Chong Zhang, Zuoyan Zhang, Yueyi Wu

|Jun 02, 2022
DYRK1A reinforces epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma via cooperatively activating STAT3 and SMAD.

Yang-Ling Li, Man-Man Zhang, Lin-Wen Wu

|May 24, 2022
The Overexpression of SLC25A13 Predicts Poor Prognosis and Is Correlated with Immune Cell Infiltration in Patients with Skin Cutaneous Melanoma.

Yue Lv, Chun-Hui Yuan, Lu-Yao Han

|May 09, 2022
Erratum to DYRK1A suppression restrains Mcl-1 expression and sensitizes NSCLC cells to Bcl-2 inhibitors.

Yangling Li, Dongmei Zhou, Shuang Xu

|Feb 08, 2022
Ferroptosis in cancer and cancer immunotherapy.

Lei Zhao, Xiaoxue Zhou, Feng Xie

|Aug 23, 2020
ApoC1 promotes the metastasis of clear cell renal cell carcinoma via activation of STAT3.

Yang-Ling Li, Lin-Wen Wu, Ling-Hui Zeng

Pageof 2

Frequent Collaborators

3 joint publications

Nengming Lin

2 joint publications

Yangling Li

1 joint publications

Rong-Biao Ying

1 joint publications

Wei Wang